Pharmafile Logo

Medscape Online Continuing Medical Education Led to New Diagnoses in Alzheimer’s Disease

June 2, 2025 | RWO, Real World Outcomes 

- PMLiVE

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer’s disease diagnosis.

Read the full article here. 

The study, published in JMIR Medical Education, looks at the impact of Medscape’s online education in Alzheimer’s disease using Real-World Outcomes. The results showed a significant increase in the volume of Alzheimer’s diagnoses (F1900 = 5.50; P = .02) following Medscape’s online CME, resulting in several thousand more estimated diagnoses annually.

“A timely diagnosis of Alzheimer’s disease makes a real difference to patients’ and caregivers’ lives. This study found CME learners’ increase in new diagnoses was 1.6 times greater than nonlearners’, leading to an estimated 7939 new diagnoses annually. This study highlights rigorous evaluation of Medscape’s CME and the power of our online education to drive meaningful differences in real-world patient care,” said Medscape Education Chief Impact Officer Katie Lucero, PhD.

Medscape Education has a commitment to publishing the outcomes and impact of their education in leading journals and at medical conferences around the world. Medscape Education published 145 studies, posters, abstracts, and other publications in 2024.

For more information on Medscape’s Real-World Outcomes please fill out this form here

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals

 

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

#ShortenTheJourney

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Why Sleep Health is the Missing Link in Women’s Wellness

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.